Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in GlioblastomaKai Huang, Chunsheng Kang, Junhu Zhou et al.|Advanced Science|2019Cited by 106
Identification of FOXM1 as a specific marker for triple‑negative breast cancerYanli Tan, Bo Zhang|International Journal of Oncology|2018Cited by 64
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse gliomaJing Feng, Xiaolong Fan, Zheng Zhao et al.|Frontiers of Medicine|2023Cited by 4